NASDAQ:KRYS

Krystal Biotech Stock Insider Trading

etoro logo Buy KRYS
*Your capital is at risk
$301.82
+8.61 (+2.94%)
At Close: Jun 03, 2026

Krystal Biotech Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -37.44. In total, the insiders bought 553.96K and sold 188.03K KRYS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-37.44
Buy 553.96K shares
Sell 188.03K shares
44% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
Feb 27, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -37.44.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
May 26, 2026
Sell
Common Stock
S-Sale
Thomas John Charles
EVP, General Counsel
Officer 642
Value: $193.9K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Krish S
President And CEO
CEO / President 8 798
Value: $2.33M
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Suma
President, R&d
CEO / President 407
Value: $104.7K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Suma
President, R&d
CEO / President 589
Value: $152.3K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Suma
President, R&d
CEO / President 668
Value: $173.4K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Suma
President, R&d
CEO / President 3 667
Value: $954.8K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Suma
President, R&d
CEO / President 2 931
Value: $766.2K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Suma
President, R&d
CEO / President 1 938
Value: $508.4K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Suma
President, R&d
CEO / President 2 248
Value: $592.5K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Suma
President, R&d
CEO / President 4 852
Value: $1.28M
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Krish S
President And CEO
CEO / President 2 043
Value: $538.7K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Krish S
President And CEO
CEO / President 2 380
Value: $624.6K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Krish S
President And CEO
CEO / President 2 962
Value: $774.3K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Krish S
President And CEO
CEO / President 3 128
Value: $814.8K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Krish S
President And CEO
CEO / President 1 377
Value: $357.8K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Krish S
President And CEO
CEO / President 470
Value: $121.4K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Krish S
President And CEO
CEO / President 483
Value: $124.3K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Suma
President, R&d
CEO / President 1 700
Value: $452.9K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Suma
President, R&d
CEO / President 6 000
Value: $1.59M
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Krish S
President And CEO
CEO / President 920
Value: $245.2K
Mar 04, 2026
Sell
Common Stock
S-Sale
Krishnan Krish S
President And CEO
CEO / President 2 439
Value: $647.8K
Mar 02, 2026
Sell
Common Stock
S-Sale
Romano Kathryn
Chief Accounting Officer
Officer 750
Value: $200.7K
Mar 01, 2026
Buy
Stock Option (Right to Buy)
Thomas John Charles
EVP, General Counsel
Officer 32 400
Value: $1.69M
Mar 01, 2026
Buy
Stock Option (Right to Buy)
Thomas John Charles
EVP, General Counsel
Officer 1 350
Value: $85.8K
Mar 01, 2026
Buy
Stock Option (Right to Buy)
Thomas John Charles
EVP, General Counsel
Officer 8 650
Value: $708.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT KRYSTAL BIOTECH INC
Krystal Biotech
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive con...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE